Service hospitalier de psychiatrie : Questions médicales fréquentes
Nom anglais: Psychiatric Department, Hospital
Descriptor UI:D011567
Tree Number:N04.452.442.452.422.641
Termes MeSH sélectionnés :
Prostate-Specific Antigen
Questions fréquentes et termes MeSH associés
Diagnostic
5
#1
Comment un diagnostic psychiatrique est-il établi ?
Il repose sur des entretiens cliniques, des évaluations psychologiques et des critères DSM.
DiagnosticTroubles mentaux
#2
Quels outils sont utilisés pour le diagnostic ?
Des questionnaires, des échelles d'évaluation et des tests psychologiques sont utilisés.
Évaluation psychologiqueTests psychologiques
#3
Quelles sont les principales catégories de troubles ?
Les troubles de l'humeur, anxieux, psychotiques et de la personnalité sont principaux.
Troubles de l'humeurTroubles anxieux
#4
Le diagnostic peut-il changer avec le temps ?
Oui, il peut évoluer en fonction des symptômes et des réponses au traitement.
Évolution des symptômesSuivi clinique
#5
Qui peut poser un diagnostic psychiatrique ?
Un psychiatre ou un professionnel de la santé mentale qualifié peut établir un diagnostic.
PsychiatreProfessionnels de la santé mentale
Symptômes
5
#1
Quels sont les symptômes courants des troubles mentaux ?
Les symptômes incluent l'anxiété, la dépression, les hallucinations et les troubles de l'humeur.
Symptômes psychiatriquesTroubles de l'humeur
#2
Comment reconnaître une crise d'angoisse ?
Elle se manifeste par des palpitations, des sueurs, des tremblements et une peur intense.
Crise d'angoisseTroubles anxieux
#3
Les symptômes peuvent-ils varier d'une personne à l'autre ?
Oui, l'expression des symptômes peut être très individuelle selon les personnes.
Variabilité des symptômesTroubles mentaux
#4
Quels signes indiquent une dépression sévère ?
Une perte d'intérêt, des troubles du sommeil, de l'appétit et des pensées suicidaires.
DépressionPensées suicidaires
#5
Les symptômes physiques sont-ils fréquents ?
Oui, des douleurs corporelles et des troubles digestifs peuvent accompagner les troubles mentaux.
Symptômes physiquesTroubles psychosomatiques
Prévention
5
#1
Comment prévenir les troubles mentaux ?
La prévention passe par l'éducation, le soutien social et la gestion du stress.
PréventionGestion du stress
#2
Le soutien familial joue-t-il un rôle ?
Oui, un bon soutien familial peut réduire le risque de troubles mentaux.
Soutien familialFacteurs de risque
#3
Les programmes scolaires peuvent-ils aider ?
Oui, ils peuvent enseigner des compétences de vie et de gestion des émotions.
Programmes scolairesCompétences de vie
#4
L'activité physique aide-t-elle à prévenir les troubles ?
Oui, l'exercice régulier est bénéfique pour la santé mentale et le bien-être.
Activité physiqueSanté mentale
#5
Les techniques de relaxation sont-elles utiles ?
Oui, des techniques comme la méditation et le yoga peuvent réduire le stress.
Techniques de relaxationMéditation
Traitements
5
#1
Quels types de traitements sont disponibles en psychiatrie ?
Les traitements incluent la psychothérapie, la médication et les thérapies alternatives.
PsychothérapieMédicaments psychiatriques
#2
Comment fonctionne la psychothérapie ?
Elle aide à explorer les pensées et comportements pour améliorer le bien-être mental.
PsychothérapieThérapie comportementale
#3
Quels médicaments sont couramment prescrits ?
Les antidépresseurs, anxiolytiques et antipsychotiques sont fréquemment utilisés.
AntidépresseursAntipsychotiques
#4
La thérapie de groupe est-elle efficace ?
Oui, elle favorise le soutien social et l'échange d'expériences entre patients.
Thérapie de groupeSoutien social
#5
Qu'est-ce que la thérapie électroconvulsive ?
C'est un traitement pour les cas sévères de dépression, utilisant des impulsions électriques.
Thérapie électroconvulsiveDépression sévère
Complications
5
#1
Quelles complications peuvent survenir avec les troubles mentaux ?
Des complications incluent l'isolement social, les problèmes de santé physique et le suicide.
Isolement socialSuicide
#2
Les troubles mentaux augmentent-ils le risque de maladies physiques ?
Oui, ils peuvent augmenter le risque de maladies cardiovasculaires et métaboliques.
Maladies cardiovasculairesSanté physique
#3
Comment l'usage de substances affecte-t-il la santé mentale ?
L'abus de substances peut aggraver les troubles mentaux et compliquer le traitement.
Abus de substancesTroubles mentaux
#4
Les troubles mentaux peuvent-ils affecter la vie professionnelle ?
Oui, ils peuvent entraîner des absences, une baisse de productivité et des conflits.
Vie professionnelleProductivité
#5
Quelles sont les conséquences du suicide ?
Le suicide a des conséquences dévastatrices pour la famille, les amis et la communauté.
SuicideConséquences sociales
Facteurs de risque
5
#1
Quels sont les facteurs de risque des troubles mentaux ?
Les facteurs incluent l'hérédité, le stress, les traumatismes et l'isolement social.
Facteurs de risqueTraumatismes
#2
Le stress au travail peut-il être un facteur de risque ?
Oui, un environnement de travail stressant peut contribuer au développement de troubles mentaux.
Stress au travailSanté mentale
#3
Les antécédents familiaux influencent-ils le risque ?
Oui, un historique familial de troubles mentaux augmente le risque chez les individus.
Antécédents familiauxHérédité
#4
Les événements traumatiques augmentent-ils le risque ?
Oui, les traumatismes peuvent déclencher ou aggraver des troubles mentaux.
Événements traumatiquesTroubles mentaux
#5
L'isolement social est-il un facteur de risque ?
Oui, l'isolement social peut exacerber les symptômes et augmenter le risque de troubles.
Isolement socialFacteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Service hospitalier de psychiatrie : Questions médicales les plus fréquentes",
"headline": "Service hospitalier de psychiatrie : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Service hospitalier de psychiatrie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-20",
"dateModified": "2025-02-14",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Service hospitalier de psychiatrie"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Services hospitaliers",
"url": "https://questionsmedicales.fr/mesh/D006748",
"about": {
"@type": "MedicalCondition",
"name": "Services hospitaliers",
"code": {
"@type": "MedicalCode",
"code": "D006748",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N04.452.442.452.422"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Service hospitalier de psychiatrie",
"alternateName": "Psychiatric Department, Hospital",
"code": {
"@type": "MedicalCode",
"code": "D011567",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Giuseppe Nicolò",
"url": "https://questionsmedicales.fr/author/Giuseppe%20Nicol%C3%B2",
"affiliation": {
"@type": "Organization",
"name": "Dipartimento di Salute Mentale e Dipendenze Patologiche, ASL Roma 5."
}
},
{
"@type": "Person",
"name": "Michael P Wilson",
"url": "https://questionsmedicales.fr/author/Michael%20P%20Wilson",
"affiliation": {
"@type": "Organization",
"name": "Department of Emergency Medicine, University of Arkansas for Medical Sciences, Little Rock, AR."
}
},
{
"@type": "Person",
"name": "Brittany M Gouse",
"url": "https://questionsmedicales.fr/author/Brittany%20M%20Gouse",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychiatry, Boston University Chobanian & Avedisian School of Medicine, Boston 02118, USA; Wellness and Recovery After Psychosis Research Program, Boston Medical Center, Boston, MA 02118, USA. Electronic address: Brittany.gouse@bmc.org."
}
},
{
"@type": "Person",
"name": "Rachel Oblath",
"url": "https://questionsmedicales.fr/author/Rachel%20Oblath",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychiatry, Boston University Chobanian & Avedisian School of Medicine, Boston 02118, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The Impact of Receipt of Information on Prostate-Specific Antigen Testing on Screening with the Prostate-Specific Antigen Test.",
"datePublished": "2023-01-18",
"url": "https://questionsmedicales.fr/article/36652189",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s13187-023-02264-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prostate-Specific Antigen Screening in Transgender Patients.",
"datePublished": "2022-11-04",
"url": "https://questionsmedicales.fr/article/36344317",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.eururo.2022.09.007"
}
},
{
"@type": "ScholarlyArticle",
"name": "Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy.",
"datePublished": "2022-07-21",
"url": "https://questionsmedicales.fr/article/35860909",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/pros.24414"
}
},
{
"@type": "ScholarlyArticle",
"name": "Total Prostate Specific Antigen in Prostate Cancer Screening in Hyperglycemic Individuals.",
"datePublished": "2022-09-24",
"url": "https://questionsmedicales.fr/article/36253300",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.clgc.2022.09.007"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Opportunities for prostate-specific membrane antigen hybrid imaging in prostate cancer].",
"datePublished": "2023-09-13",
"url": "https://questionsmedicales.fr/article/37702749",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00120-023-02189-z"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Administration des services de santé",
"item": "https://questionsmedicales.fr/mesh/D006298"
},
{
"@type": "ListItem",
"position": 3,
"name": "Organisation et administration",
"item": "https://questionsmedicales.fr/mesh/D009934"
},
{
"@type": "ListItem",
"position": 4,
"name": "Administration d'établissement de santé",
"item": "https://questionsmedicales.fr/mesh/D058016"
},
{
"@type": "ListItem",
"position": 5,
"name": "Administration hospitalière",
"item": "https://questionsmedicales.fr/mesh/D006739"
},
{
"@type": "ListItem",
"position": 6,
"name": "Services hospitaliers",
"item": "https://questionsmedicales.fr/mesh/D006748"
},
{
"@type": "ListItem",
"position": 7,
"name": "Service hospitalier de psychiatrie",
"item": "https://questionsmedicales.fr/mesh/D011567"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Service hospitalier de psychiatrie - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Service hospitalier de psychiatrie",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Service hospitalier de psychiatrie",
"description": "Comment un diagnostic psychiatrique est-il établi ?\nQuels outils sont utilisés pour le diagnostic ?\nQuelles sont les principales catégories de troubles ?\nLe diagnostic peut-il changer avec le temps ?\nQui peut poser un diagnostic psychiatrique ?",
"url": "https://questionsmedicales.fr/mesh/D011567?mesh_terms=Prostate-Specific+Antigen#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Service hospitalier de psychiatrie",
"description": "Quels sont les symptômes courants des troubles mentaux ?\nComment reconnaître une crise d'angoisse ?\nLes symptômes peuvent-ils varier d'une personne à l'autre ?\nQuels signes indiquent une dépression sévère ?\nLes symptômes physiques sont-ils fréquents ?",
"url": "https://questionsmedicales.fr/mesh/D011567?mesh_terms=Prostate-Specific+Antigen#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Service hospitalier de psychiatrie",
"description": "Comment prévenir les troubles mentaux ?\nLe soutien familial joue-t-il un rôle ?\nLes programmes scolaires peuvent-ils aider ?\nL'activité physique aide-t-elle à prévenir les troubles ?\nLes techniques de relaxation sont-elles utiles ?",
"url": "https://questionsmedicales.fr/mesh/D011567?mesh_terms=Prostate-Specific+Antigen#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Service hospitalier de psychiatrie",
"description": "Quels types de traitements sont disponibles en psychiatrie ?\nComment fonctionne la psychothérapie ?\nQuels médicaments sont couramment prescrits ?\nLa thérapie de groupe est-elle efficace ?\nQu'est-ce que la thérapie électroconvulsive ?",
"url": "https://questionsmedicales.fr/mesh/D011567?mesh_terms=Prostate-Specific+Antigen#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Service hospitalier de psychiatrie",
"description": "Quelles complications peuvent survenir avec les troubles mentaux ?\nLes troubles mentaux augmentent-ils le risque de maladies physiques ?\nComment l'usage de substances affecte-t-il la santé mentale ?\nLes troubles mentaux peuvent-ils affecter la vie professionnelle ?\nQuelles sont les conséquences du suicide ?",
"url": "https://questionsmedicales.fr/mesh/D011567?mesh_terms=Prostate-Specific+Antigen#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Service hospitalier de psychiatrie",
"description": "Quels sont les facteurs de risque des troubles mentaux ?\nLe stress au travail peut-il être un facteur de risque ?\nLes antécédents familiaux influencent-ils le risque ?\nLes événements traumatiques augmentent-ils le risque ?\nL'isolement social est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D011567?mesh_terms=Prostate-Specific+Antigen#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment un diagnostic psychiatrique est-il établi ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il repose sur des entretiens cliniques, des évaluations psychologiques et des critères DSM."
}
},
{
"@type": "Question",
"name": "Quels outils sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des questionnaires, des échelles d'évaluation et des tests psychologiques sont utilisés."
}
},
{
"@type": "Question",
"name": "Quelles sont les principales catégories de troubles ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les troubles de l'humeur, anxieux, psychotiques et de la personnalité sont principaux."
}
},
{
"@type": "Question",
"name": "Le diagnostic peut-il changer avec le temps ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut évoluer en fonction des symptômes et des réponses au traitement."
}
},
{
"@type": "Question",
"name": "Qui peut poser un diagnostic psychiatrique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un psychiatre ou un professionnel de la santé mentale qualifié peut établir un diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des troubles mentaux ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent l'anxiété, la dépression, les hallucinations et les troubles de l'humeur."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une crise d'angoisse ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par des palpitations, des sueurs, des tremblements et une peur intense."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils varier d'une personne à l'autre ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'expression des symptômes peut être très individuelle selon les personnes."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une dépression sévère ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une perte d'intérêt, des troubles du sommeil, de l'appétit et des pensées suicidaires."
}
},
{
"@type": "Question",
"name": "Les symptômes physiques sont-ils fréquents ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs corporelles et des troubles digestifs peuvent accompagner les troubles mentaux."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles mentaux ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par l'éducation, le soutien social et la gestion du stress."
}
},
{
"@type": "Question",
"name": "Le soutien familial joue-t-il un rôle ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un bon soutien familial peut réduire le risque de troubles mentaux."
}
},
{
"@type": "Question",
"name": "Les programmes scolaires peuvent-ils aider ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent enseigner des compétences de vie et de gestion des émotions."
}
},
{
"@type": "Question",
"name": "L'activité physique aide-t-elle à prévenir les troubles ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier est bénéfique pour la santé mentale et le bien-être."
}
},
{
"@type": "Question",
"name": "Les techniques de relaxation sont-elles utiles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des techniques comme la méditation et le yoga peuvent réduire le stress."
}
},
{
"@type": "Question",
"name": "Quels types de traitements sont disponibles en psychiatrie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la psychothérapie, la médication et les thérapies alternatives."
}
},
{
"@type": "Question",
"name": "Comment fonctionne la psychothérapie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle aide à explorer les pensées et comportements pour améliorer le bien-être mental."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont couramment prescrits ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antidépresseurs, anxiolytiques et antipsychotiques sont fréquemment utilisés."
}
},
{
"@type": "Question",
"name": "La thérapie de groupe est-elle efficace ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle favorise le soutien social et l'échange d'expériences entre patients."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que la thérapie électroconvulsive ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est un traitement pour les cas sévères de dépression, utilisant des impulsions électriques."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les troubles mentaux ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent l'isolement social, les problèmes de santé physique et le suicide."
}
},
{
"@type": "Question",
"name": "Les troubles mentaux augmentent-ils le risque de maladies physiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent augmenter le risque de maladies cardiovasculaires et métaboliques."
}
},
{
"@type": "Question",
"name": "Comment l'usage de substances affecte-t-il la santé mentale ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'abus de substances peut aggraver les troubles mentaux et compliquer le traitement."
}
},
{
"@type": "Question",
"name": "Les troubles mentaux peuvent-ils affecter la vie professionnelle ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent entraîner des absences, une baisse de productivité et des conflits."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences du suicide ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le suicide a des conséquences dévastatrices pour la famille, les amis et la communauté."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque des troubles mentaux ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'hérédité, le stress, les traumatismes et l'isolement social."
}
},
{
"@type": "Question",
"name": "Le stress au travail peut-il être un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un environnement de travail stressant peut contribuer au développement de troubles mentaux."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un historique familial de troubles mentaux augmente le risque chez les individus."
}
},
{
"@type": "Question",
"name": "Les événements traumatiques augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traumatismes peuvent déclencher ou aggraver des troubles mentaux."
}
},
{
"@type": "Question",
"name": "L'isolement social est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'isolement social peut exacerber les symptômes et augmenter le risque de troubles."
}
}
]
}
]
}
Department of Psychiatry, Boston University Chobanian & Avedisian School of Medicine, Boston 02118, USA; Wellness and Recovery After Psychosis Research Program, Boston Medical Center, Boston, MA 02118, USA. Electronic address: Brittany.gouse@bmc.org.
Publications dans "Service hospitalier de psychiatrie" :
Department of Psychiatry, Boston University Chobanian & Avedisian School of Medicine, Boston 02118, USA; Wellness and Recovery After Psychosis Research Program, Boston Medical Center, Boston, MA 02118, USA.
Publications dans "Service hospitalier de psychiatrie" :
Dr. Dike is Associate Professor of Psychiatry, Yale University School of Medicine, New Haven, CT, and Medical Director, Office of the Commissioner, Connecticut Department of Mental Health and Addiction Services, Hartford, CT. Ms. Bugella is CEO, Bugella Behavioral Healthcare Consulting, LLC, Berlin, CT. Dr. Hillbrand is Assistant Clinical Professor of Psychiatry, Yale University School of Medicine, New Haven, CT. Charles.dike@yale.edu.
Publications dans "Service hospitalier de psychiatrie" :
Dr. Dike is Associate Professor of Psychiatry, Yale University School of Medicine, New Haven, CT, and Medical Director, Office of the Commissioner, Connecticut Department of Mental Health and Addiction Services, Hartford, CT. Ms. Bugella is CEO, Bugella Behavioral Healthcare Consulting, LLC, Berlin, CT. Dr. Hillbrand is Assistant Clinical Professor of Psychiatry, Yale University School of Medicine, New Haven, CT.
Publications dans "Service hospitalier de psychiatrie" :
Dr. Dike is Associate Professor of Psychiatry, Yale University School of Medicine, New Haven, CT, and Medical Director, Office of the Commissioner, Connecticut Department of Mental Health and Addiction Services, Hartford, CT. Ms. Bugella is CEO, Bugella Behavioral Healthcare Consulting, LLC, Berlin, CT. Dr. Hillbrand is Assistant Clinical Professor of Psychiatry, Yale University School of Medicine, New Haven, CT.
Publications dans "Service hospitalier de psychiatrie" :
Department of Mental Health Research (King, Joyce, Nash) and McLean Franciscan Department of Child and Adolescent Mental Health Programs (Buonopane, Sossong), Franciscan Children's, Brighton, Massachusetts; Division of Depression and Anxiety Disorders (King, Ressler) and Division of Child and Adolescent Psychiatry (Buonopane, Sossong), McLean Hospital, Belmont, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston (Ressler).
Publications dans "Service hospitalier de psychiatrie" :
Department of Mental Health Research (King, Joyce, Nash) and McLean Franciscan Department of Child and Adolescent Mental Health Programs (Buonopane, Sossong), Franciscan Children's, Brighton, Massachusetts; Division of Depression and Anxiety Disorders (King, Ressler) and Division of Child and Adolescent Psychiatry (Buonopane, Sossong), McLean Hospital, Belmont, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston (Ressler).
Publications dans "Service hospitalier de psychiatrie" :
Department of Mental Health Research (King, Joyce, Nash) and McLean Franciscan Department of Child and Adolescent Mental Health Programs (Buonopane, Sossong), Franciscan Children's, Brighton, Massachusetts; Division of Depression and Anxiety Disorders (King, Ressler) and Division of Child and Adolescent Psychiatry (Buonopane, Sossong), McLean Hospital, Belmont, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston (Ressler).
Publications dans "Service hospitalier de psychiatrie" :
Department of Mental Health Research (King, Joyce, Nash) and McLean Franciscan Department of Child and Adolescent Mental Health Programs (Buonopane, Sossong), Franciscan Children's, Brighton, Massachusetts; Division of Depression and Anxiety Disorders (King, Ressler) and Division of Child and Adolescent Psychiatry (Buonopane, Sossong), McLean Hospital, Belmont, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston (Ressler).
Publications dans "Service hospitalier de psychiatrie" :
Department of Mental Health Research (King, Joyce, Nash) and McLean Franciscan Department of Child and Adolescent Mental Health Programs (Buonopane, Sossong), Franciscan Children's, Brighton, Massachusetts; Division of Depression and Anxiety Disorders (King, Ressler) and Division of Child and Adolescent Psychiatry (Buonopane, Sossong), McLean Hospital, Belmont, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston (Ressler).
Publications dans "Service hospitalier de psychiatrie" :
There is controversy on prostate cancer screening with the prostate-specific antigen (PSA) test in the USA, and as a result, there has been an increased push for physicians to have a thorough discussi...
Approximately 0.4-1.3% of the worldwide population is transgender. Although the exact prevalence is unknown, there is an increase in open identification as transgender. Among transgender women (TW), t...
To assess our current understanding of CaP incidence and prostate-specific antigen (PSA) screening in TW....
We performed a nonsystematic narrative review of all PubMed publications through June 2022 according to the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) statement. Given ...
There is no consensus regarding PSA screening in TW from any of the major societies, and TW are largely absent from guidelines. Case report data suggest that TW with CaP may have more aggressive disea...
We are in the infancy of our understanding of PSA screening in TW. Important avenues for future research include understanding the risks/benefits of PSA screening in TW, how best to mitigate potential...
We examined patterns of prostate cancer screening for transgender women. Little is known about prostate cancer incidence or screening in this population. Additional research is needed to establish gui...
Prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (RLT) is increasingly incorporated in the therapeutic algorithm of patients with metastatic castration-resistant prostate cancer ...
In this bicentric analysis, we included 184 mCRPC patients treated with...
A total of 114/184 patients (62.0%) showed any PSA decline (PSA response >50%, 55/184 [29.9%]). For individuals exhibiting a PSA decline >50%, OS of 19 months was significantly longer relative to nonr...
In mCRPC patients scheduled for RLT, early biochemical response was tightly linked to prolonged survival, irrespective of the magnitude of PSA decline. As such, even in patients with PSA decrease of l...
In this study, it was aimed to investigate the reliability of total prostate-specific antigen (t-PSA) in prostate cancer screening in hyperglycemic (≥126 mg/dL) individuals....
This research was planned as a cross-sectional retrospective study. Three hundred eleven cases which underwent biopsy with the suspicion of prostate cancer in the hospital were included in the study. ...
It was determined that the t-PSA measurement was higher in the patient group with cancer (P < .001). It was determined that the median t-PSA levels of the intermediate and high cancer groups were high...
As a contribution to literature, we found that the t-PSA test lost its sensitivity in cases with plasma glucose levels above normal. Loss of sensitivity may result in underdiagnosis in prostate cancer...
Prostate-specific membrane antigen (PSMA) hybrid imaging is a promising new technique gaining importance in the field of prostate cancer (PCa) diagnosis and treatment planning. By combining PSMA radio...
Prostate-specific antigen (PSA) screening for prostate cancer is controversial but may be associated with benefit for certain high-risk groups....
To evaluate associations of county-level PSA screening prevalence with prostate cancer outcomes, as well as variation by sociodemographic and clinical factors....
This cohort study used data from cancer registries based in 8 US states on Hispanic, non-Hispanic Black, and non-Hispanic White men aged 40 to 99 years who received a diagnosis of prostate cancer betw...
County-level PSA screening prevalence was estimated using the Behavior Risk Factor Surveillance System survey data from 2004, 2006, 2008, 2010, and 2012 and weighted by population characteristics....
Multivariable logistic, Cox proportional hazards regression, and competing risks models were fit to estimate adjusted odds ratios (AOR) and adjusted hazard ratios (AHR) for associations of county-leve...
Of 814 987 men with prostate cancer, the mean (SD) age was 67.3 (9.8) years, 7.8% were Hispanic, 12.2% were non-Hispanic Black, and 80.0% were non-Hispanic White; 17.0% had advanced disease. There wer...
This population-based cohort study of men with prostate cancer suggests that higher county-level prevalence of PSA screening was associated with lower odds of advanced disease, all-cause mortality, an...
The incidence rate of prostate cancer (PCa) has continued to rise in Korea. This study aimed to construct and evaluate a 5-year PCa risk prediction model using a cohort with PSA < 10 ng/mL by incorpor...
The PCa risk prediction model including PSA levels and individual risk factors was constructed using a cohort of 69,319 participants from the Kangbuk Samsung Health Study. 201 registered PCa incidence...
The risk prediction model included age, smoking status, alcohol consumption, family history of PCa, past medical history of dyslipidemia, cholesterol levels, and PSA level. Especially, an elevated PSA...
Our risk prediction model was effective in predicting PCa in a population according to PSA levels. When PSA levels are inconclusive, an assessment of both PSA and specific individual risk factors (e.g...
For metastatic hormone naïve prostate cancer patients, androgen deprivation therapy (ADT) with escalation therapy including docetaxel and/or androgen targeting drugs is the standard therapy. However, ...
Prostate biopsies from 92 patients with metastatic hormone naïve PC (PSA > 80 ng/mL or clinical metastases) were immunohistochemically evaluated for PSA and Ki67. Gene expression analysis was performe...
The immunohistochemical score for PSA was the strongest prognostic factor for progression-free and overall survival after ADT. Consequently, the ratio between Ki67 and PSA displayed a stronger prognos...
PSA and Ki67 immunoreactive scores are prognostic in the metastatic hormone-sensitive setting, with PSA being superior. The combination of Ki67 and PSA did not give additional prognostic value. The re...
To investigate the value of serum free prostate-specific antigen density (fPSAD) in the diagnosis of prostate cancer (PCa)....
The data of 558 patients who underwent transrectal ultrasound-guided prostate biopsy were retrospectively analyzed. According to the pathological results, the patients were divided into a PCa group an...
tPSA, PSAD, (f/t)/PSAD, and fPSAD had high accuracy in predicting PCa with AUC values of 0.820, 0.900, 0.846, and 0.867. fPSAD showed lower diagnostic sensitivity but significantly higher specificity ...
With the optimal cutoff value of 0.062, fPSAD has a higher diagnostic value for PCa than tPSA, f/tPSA, (f/t)/PSAD, and PSAD, and can well predict the risk of PCa, significantly improve the clinical di...
Benign prostatic hyperplasia (BPH) is the most common cause of bladder outlet obstruction in men over the age of 50 years. An association between the prostate specific antigen (PSA), International Pro...
To determine the correlation between the PSA, IPSS and PV in men of African descent....
This was a cross sectional analysis involving 92 patients diagnosed as having symptomatic BPH at the Ho Teaching Hospital....
The data were collected using standardised questionnaires. The IPSS determined urinary symptom severity. The PV was determined using a transabdominal ultrasound machine. Serum PSA was retrieved from t...
The mean PV was 61.04 cm3 ± 21.95 cm3, the mean PSA was 4.21 ng/mL ± 3.85 ng/mL, and mean IPSS of 21.59 ± 3.78. The Pearson's correlation between PV and PSA was 0.283 (p = 0.01), between PV and IPSS w...
This study showed that serum PSA has a positive correlation with PV. However, IPSS had no significant association with PSA or PV in patients with BPH.Contribution: This study provides insights into th...
